Xtx Topco LTD Moderna, Inc. Transaction History

Xtx Topco LTD

$1.72 Billion
Q3 2025

A detailed history of Xtx Topco LTD transactions in Moderna, Inc. stock. As of the latest transaction made, Xtx Topco LTD holds 36,755 shares of MRNA stock, worth $910,053. This represents 0.06% of its overall portfolio holdings.

Number of Shares

36,755

Holding current value

$910,053

% of portfolio

0.06%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	BUY	$23.51 - $34.67 $864,110 - $1.27 Million	36,755 New	36,755 $949,000
Q1 2025 May 07, 2025	BUY	$28.35 - $47.53 $772,168 - $1.29 Million	27,237 Added 566.02%	32,049 $908,000
Q4 2024 Feb 13, 2025	SELL	$36.85 - $63.93 $863,911 - $1.5 Million	-23,444 Reduced 82.97%	4,812 $200,000
Q3 2024 Nov 14, 2024	BUY	$63.64 - $125.14 $1.62 Million - $3.18 Million	25,400 Added 889.36%	28,256 $1.89 Million
Q2 2024 Aug 12, 2024	SELL	$101.21 - $166.61 $1.34 Million - $2.21 Million	-13,243 Reduced 82.26%	2,856 $339,000

Q1 2024 May 13, 2024	BUY	$85.37 - $115.44 $1.37 Million - $1.86 Million	16,099 New	16,099 $1.72 Million
Q2 2023 Aug 14, 2023	BUY	$118.5 - $160.53 $242,925 - $329,086	2,050 New	2,050 $249,000
Q4 2022 Feb 14, 2023	BUY	$118.38 - $210.04 $512,230 - $908,843	4,327 New	4,327 $777,000
Q2 2022 Aug 15, 2022	SELL	$117.13 - $176.59 $84,567 - $127,497	-722 Reduced 17.24%	3,466 $495,000
Q1 2022 May 13, 2022	SELL	$126.46 - $235.05 $122,792 - $228,233	-971 Reduced 18.82%	4,188 $721,000
Q4 2021 Feb 11, 2022	SELL	$225.82 - $368.51 $242,530 - $395,779	-1,074 Reduced 17.23%	5,159 $1.31 Million
Q3 2021 Nov 12, 2021	BUY	$221.9 - $484.47 $1.18 Million - $2.57 Million	5,299 Added 567.34%	6,233 $2.4 Million
Q2 2021 Aug 12, 2021	BUY	$129.91 - $234.98 $121,335 - $219,471	934 New	934 $219,000

Others Institutions Holding MRNA

# of Institutions

843

Shares Held

257M

Call Options Held

39.6M

Put Options Held

43.1M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $9.69B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

News

Stay updated on Xtx Topco LTD with notifications on news.

Account